Medical News: FDA Warns of Bladder Cancer Risk With Actos - in Primary Care, Diabetes from MedPage Today

Medical News: FDA Warns of Bladder Cancer Risk With Actos - in Primary Care, Diabetes from MedPage Today:

"Patients taking pioglitazone (Actos) for more than a year may have an increased risk of bladder cancer, according to an FDA interim review of an ongoing epidemiological study."